Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux

Thrombosis Research

Volumn 127, Issue 2, 2011, Pages 135-140

  Szlam, Fania ^a   Sreeram, Gautam ^a   Solomon, Cristina ^b   Levy, Jerrold H ^a   Molinaro, Ross J ^a   Tanaka, Kenichi A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Salzburger Landeskliniken SALK ^*  (Austria)

Author keywords

Factor VIII; Hemodilution; Thrombin Generation

Indexed keywords

ACTIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; FONDAPARINUX; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; HEMOPHILIA A; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; THROMBIN TIME; THROMBOSIS;

ANTICOAGULANTS; FACTOR VIIA; FACTOR VIII; FACTOR X; FACTOR XI DEFICIENCY; HEMOPHILIA A; HUMANS; POLYSACCHARIDES; RECOMBINANT PROTEINS; THROMBIN; VON WILLEBRAND FACTOR; WHOLE BLOOD COAGULATION TIME;

EID: 79151482034     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.10.017     Document Type: Article

References (44)

1. E. Jaffe Synthesis of factor VIII by endothelial cells Ann NY Acad Sci 401 1982 163 170
2. S. Yuan, C. Ferrell, and W.L. Chandler Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma Thromb Res 120 2007 29 37
3. L.A. Harker, T.W. Malpass, H.E. Branson, E.A. Hessel II, and S.J. Slichter Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release Blood 56 1980 824 834
4. D. Bolliger, F. Szlam, R.J. Molinaro, N. Rahe-Meyer, J.H. Levy, and K.A. Tanaka Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model Br J Anaesth 102 2009 793 799
5. J. Ingerslev, and I. Hvid Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment Semin Hematol 43 2006 S23 S26
6. C.L. Kempton, M.A. Escobar, and H.R. Roberts Hemophilia care in the 21st century Clin Adv Hematol Oncol 2 2004 733 740
7. A. Brack, S. Vogeler, J. Hilpert, G. Berger, H.J. Buhr, and J. Koscielny Acquired factor VIII inhibitor Anesthesiology 111 2009 1151 1154
8. R. Asakai, D.W. Chung, E.W. Davie, and U. Seligsohn Factor XI deficiency in Ashkenazi Jews in Israel N Engl J Med 325 1991 153 158
9. P.H. Bolton-Maggs, D.A. Patterson, R.T. Wensley, and E.G. Tuddenham Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study Thromb Haemost 73 1995 194 202
10. D. Bolliger, F. Szlam, J.H. Levy, R.J. Molinaro, and K.A. Tanaka Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage Br J Anaesth 104 2010 318 325
11. Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010;103:718-27.
12. M.Y. Chan, M.G. Cohen, C.K. Dyke, S.K. Myles, L.G. Aberle, and M. Lin Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease Circulation 117 2008 2865 2874
13. D.V. Kravtsov, A. Matafonov, E.I. Tucker, M.F. Sun, P.N. Walsh, and A. Gruber Factor XI contributes to thrombin generation in the absence of factor XII Blood 114 2009 452 458
14. H. Desmurs-Clavel, C. Huchon, B. Chatard, C. Negrier, and Y. Dargaud Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC Thromb Res 123 2009 796 798
15. P.M. Mannucci, V. Vicente, I. Alberca, E. Sacchi, G. Longo, and A.S. Harris Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses Thromb Haemost 58 1987 1037 1039
16. I.M. Keularts, K. Hamulyak, H.C. Hemker, and S. Beguin The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients Thromb Haemost 84 2000 638 642
17. H.C. Hemker, R. Al Dieri, E. De Smedt, and S. Beguin Thrombin generation, a function test of the haemostatic-thrombotic system Thromb Haemost 96 2006 553 561
18. U. Seligsohn Factor XI deficiency in humans J Thromb Haemost 7 Suppl 1 2009 84 87
19. Y. Dargaud, and C. Negrier Thrombin generation testing in haemophilia comprehensive care centres Haemophilia 16 2010 223 230
20. F. Szlam, T. Taketomi, C.A. Sheppard, C.L. Kempton, J.H. Levy, and K.A. Tanaka Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma Anesth Analg 106 2008 719 724
21. F. Szlam, D. Luan, D. Bolliger, A.D. Szlam, J.H. Levy, and J.D. Varner Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin Thromb Res 125 2010 432 437
22. G.A. Allen, A.S. Wolberg, J.A. Oliver, M. Hoffman, H.R. Roberts, and D.M. Monroe Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2 2004 402 413
23. K.A. Tanaka, F. Szlam, G. Dickneite, and J.H. Levy Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation Thromb Res 122 2008 117 123
24. S. Elodi, and K. Varadi Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation Thromb Res 15 1979 617 629
25. K.R. Machlus, E.A. Colby, J.R. Wu, G.G. Koch, N.S. Key, and A.S. Wolberg Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram Thromb Haemost 102 2009 936 944
26. W.L. Chandler, C. Ferrell, J. Lee, T. Tun, and H. Kha Comparison of three methods for measuring factor VIII levels in plasma Am J Clin Pathol 120 2003 34 39
27. J. Boldt, I. Huttner, S. Suttner, B. Kumle, S.N. Piper, and G. Berchthold Changes of haemostasis in patients undergoing major abdominal surgery-is there a difference between elderly and younger patients? Br J Anaesth 87 2001 435 440
28. M. Weinstein, J.A. Ware, J. Troll, and E. Salzman Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate Blood 71 1988 1648 1655
29. P.M. Mannucci, M. Aberg, I.M. Nilsson, and B. Robertson Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs Br J Haematol 30 1975 81 93
30. P.A. Carless, B.J. Stokes, A.J. Moxey, and D.A. Henry Desmopressin use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 1 2004 CD001884
31. D. Bolliger, M.D. Seeberger, J. Kasper, A. Bernheim, R.M. Schumann, and K. Skarvan Different effects of sevoflurane, desflurane, and isoflurane on early and late left ventricular diastolic function in young healthy adults Br J Anaesth 104 2010 547 554
32. J.W. Eikelboom, D.J. Quinlan, and M. O Donnell Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials Circulation 120 2009 2006 2011
33. G.T. Gerotziafas, A.D. Petropoulou, E. Verdy, M.M. Samama, and I. Elalamy Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation J Thromb Haemost 5 2007 955 962
34. A.R. Rezaie Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex Blood 97 2001 2308 2313
35. P.L. Turecek, K. Varadi, B. Keil, C. Negrier, E. Berntorp, and J. Astermark Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay Pathophysiol Haemost Thromb 33 2003 16 22
36. J. Astermark, S.M. Donfield, D.M. DiMichele, A. Gringeri, S.A. Gilbert, and J. Waters A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study Blood 109 2007 546 551
37. A. Tripodi, V. Chantarangkul, I. Martinelli, P. Bucciarelli, and P.M. Mannucci A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism Blood 104 2004 3631 3634
38. S.J. Wielders, S. Beguin, H.C. Hemker, and T. Lindhout Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available Arterioscler Thromb Vasc Biol 24 2004 1138 1142
39. O. Salomon, D.M. Steinberg, R. Dardik, N. Rosenberg, A. Zivelin, and I. Tamarin Inherited factor XI deficiency confers no protection against acute myocardial infarction J Thromb Haemost 1 2003 658 661
40. O. Salomon, D.M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn Reduced incidence of ischemic stroke in patients with severe factor XI deficiency Blood 111 2008 4113 4117
41. S. Beguin, I. Keularts, R. Al Dieri, S. Bellucci, J. Caen, and H.C. Hemker Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome J Thromb Haemost 2 2004 170 176
42. S.H. Ibbotson, H. Rayner, M.H. Stickland, J.A. Davies, and P.J. Grant Thrombin generation and factor VIII:C levels in patients with type 1 diabetes complicated by nephropathy Diabet Med 10 1993 336 340
43. S. Butenas, J.D. Dee, and K.G. Mann The function of factor XI in tissue factor-initiated thrombin generation J Thromb Haemost 1 2003 2103 2111
44. P.L. Lutsey, A.R. Folsom, S.R. Heckbert, and M. Cushman Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study J Thromb Haemost 7 2009 1639 1648